FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (devimistat) for Treatment of Soft Tissue Sarcoma

NEXT STORY
Fishawack Health Launches PsoriasIS NOT CONTAGIOUS Mask Campaign for World Psoriasis Day
PREV STORY
Sorrento Announces That Intranasal Administration of COVI-AMG™ Neutralizing Antibody Prevented COVID-19 Disease Progression in Infected Hamsters Following SARS-CoV-2 Infection
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Data Published in Nature Communications Demonstrate the Power of Fluidigm’s CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical Oncology

author_avatar
NASDAQ Market News

Calithera Biosciences to Present First Clinical Data from Development Program for Arginase Inhibitor CB-280 at NACFC 2021

author_avatar
NASDAQ Market News

Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy

CANTON, Mass., April 04, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced ...

author_avatar
NASDAQ Market News